kamath electoral bonds donated supply rise viatris biocon usd countries covid19 station rights wrote reddy bank novo life market parties billion review quarter obesity list indian given global executive bond

Articles for Biocon Biologics, search results for biologics

IIM Bangalore’s PGPEM batch hosts silver jubilee of annual leadership summit Drishti 2024
1 month, 1 week ago

IIM Bangalore’s PGPEM batch hosts silver jubilee of annual leadership summit Drishti 2024

Hindustan Times  

The Indian Institute of Management Bangalore’s Postgraduate Programme in Enterprise Management batch hosted a two-day flagship Annual Leadership Summit ‘Drishti’ at the institution’s campus on November 9 and 10, 2024. The silver jubilee edition of the summit gave a platform to industry leaders, visionaries, professionals, and business school students who came together for a collaborative deliberation on innovations for a …

Business Summit Cto Industry Leaders Iim Bangalore Drishti Silver Jubilee
Serum Institute to double investment in Biocon’s unit to $300 million
1 year, 8 months ago

Serum Institute to double investment in Biocon’s unit to $300 million

Live Mint  

As part of its expansion of investment in one of Biocon Ltd's units, Serum Institute of Life Sciences will give it access to 100 million vaccine doses annually. As per the new alliance, the company would pump in $150 million after converting a loan to Biocon Pharma Limited into equity in Biocon Biologics Ltd. The investment made is in addition …

Equity Investment Million Institute Serum Serum Institute Biocon
Saraf And Partners Acts For Viatris In Its Sale Of Biosimilars Business To Biocon Biologics For US$ 3.335 Billion
2 years ago

Saraf And Partners Acts For Viatris In Its Sale Of Biosimilars Business To Biocon Biologics For US$ 3.335 Billion

Live Law  

Global healthcare company - Viatris has, on November 29, completed the sale of its global biosimilars business to Biocon Biologics Limited, subsidiary of Biocon Limited for USD 3.335 billion for stock and cash consideration. The sale of global biosimilars business marks monumental moment to develop a future direction for Viatris that will not only unlock immediate value but will also …

India Deal Associate Partner Related Advised Biologics
Biocon Biologics Bribery Case: HC Rejects CBI's Plea for Custody of Four Accused, Allows for One
2 years, 5 months ago

Biocon Biologics Bribery Case: HC Rejects CBI's Plea for Custody of Four Accused, Allows for One

News 18  

]The Delhi High Court has rejected CBI’s plea seeking police custody of four persons, including a joint drug controller at the Central Drugs Standard Control Organisation, who were arrested in connection with a Biocon Biologics bribery case. The CBI had submitted that it required custody of the accused persons — joint drugs controller Dr. S Eswara Reddy, an alleged conduit …

Delhi Police Custody Custody Accused Reddy Cbi Kumar
Biocon Biologics Bribery Case: CBI Moves HC Challenging Lower Court Verdict Denying it Custody of Arrested Accused
2 years, 5 months ago

Biocon Biologics Bribery Case: CBI Moves HC Challenging Lower Court Verdict Denying it Custody of Arrested Accused

News 18  

The CBI approached the Delhi High Court on Tuesday challenging a lower court order denying it the custody of those arrested in the CDSCO bribery scandal allegedly involving a senior executive of Biocon Biologics, officials said. A special court here had sent all the five accused, including a joint drug controller at the Central Drugs Standard Control Organisation, to judicial …

Court Cbi Biocon Biologics
‘Minutes manipulated’: CBI arrests Biocon executive, 4 others
2 years, 6 months ago

‘Minutes manipulated’: CBI arrests Biocon executive, 4 others

Hindustan Times  

The Central Bureau of Investigation on Tuesday placed under arrest a top executive of Biocon Biologics, a drugs inspector and a joint drug controller at India’s pharma regulator, a day after the agency disclosed it booked several people over alleged bribes paid to fast-track the approval of an insulin injection developed by the company. ‘Minutes manipulated’: CBI arrests Biocon executive, …

India Trial Drugs Sec Drug Cdsco Phase
CBI arrests Joint Drugs Controller S Eswara Reddy for accepting a bribe to clear Biocon Biologic's diabetes injection
2 years, 6 months ago

CBI arrests Joint Drugs Controller S Eswara Reddy for accepting a bribe to clear Biocon Biologic's diabetes injection

Op India  

The Central Bureau of Investigation on Tuesday arrested Joint Drugs Controller S Eswara Reddy for accepting a bribe of Rs Rs 4 lakh to clear phase three trial of ‘Insulin Aspart’, an underdevelopment diabetes drug. #Breaking: CBI arrests Joint Drugs Controller, S Eswara Reddy, for allegedly receiving Rs 4 lakh bribe to waive the phase III clinical trial of Insulin …

Reddy Cbi Biologics Biocon Biocon Biologics Eswara Reddy S Eswara Reddy
‘Product approvals legitimate’, says Biocon after CBI books top CDSCO official
2 years, 6 months ago

‘Product approvals legitimate’, says Biocon after CBI books top CDSCO official

Hindustan Times  

Biocon Biologics on Tuesday denied allegations of bribery even as the Central Bureau of Investigation arrested an executive of a company allegedly operating on its behalf on charges of allegedly bribing a joint drugs controller at the Central Drugs Standard Control Organisation to waive off phase 3 clinical trial of its diabetes injection. In a statement, the agency also named …

India Delhi Drugs Reddy Cbi Pti Cdsco
Biocon subsidiary caught offering bribe to waive off trial of new drug
2 years, 6 months ago

Biocon subsidiary caught offering bribe to waive off trial of new drug

The Hindu  

The CBI on Monday, June 20, 2022, apprehended Joint Drugs Controller S. Eswara Reddy for allegedly receiving a ₹4-lakh bribe to waive phase-three clinical trial of Insulin Aspart injection, an underdevelopment product of Biocon Biologics, officials said. The CBI has alleged that the regulatory work of Biocon Biologics was looked after by Guljit Sethi of Bioinnovat Research Services Private Ltd. …

Delhi Reddy Cbi Bribe Cdsco Dua Biologics
Biocon Biologics bags $90-mn contract from Malaysian government to supply human insulin
2 years, 7 months ago

Biocon Biologics bags $90-mn contract from Malaysian government to supply human insulin

The Hindu  

Biocon Biologics Limited, a subsidiary of Biocon on Tuesday said it has bagged a three-year contract valued at $90 million from the Malaysian government for the supply of recombinant human insulin brand Insugen. Biocon Sdn Bhd., a subsidiary of Biocon Biologics, will manufacture and supply its range of insulins to its partner Duopharma Marketing Sdn. Biocon Biologics’ Insugen formulations will …

Insulin Malaysia Biologics Biocon Biocon Biologics Human Insulin
Biocon Biologics to file for IPO within next 2 years: Kiran Mazumdar-Shaw
2 years, 9 months ago

Biocon Biologics to file for IPO within next 2 years: Kiran Mazumdar-Shaw

Live Mint  

Biocon's subsidiary Biocon Biologics will file for an initial public offer within next two years, Executive Chairperson Kiran Mazumdar-Shaw on Monday informed. Biocon Biologics, which has inked a deal to acquire Viatris Inc's biosimilars business for up to ₹24,990 crore, aims to be a fully integrated global biosimilars firm. This acquisition of Viatris' biosimilar business is an important step to …

Global Debt Value Ipo Biologics Biocon Mazumdar Shaw
Biocon arm to acquire biosimilars business of Viatris for $3.34 bn
2 years, 9 months ago

Biocon arm to acquire biosimilars business of Viatris for $3.34 bn

The Hindu  

Biocon subsidiary Biocon Biologics Ltd has entered into a definitive agreement with its partner Viatris Inc to acquire Viatris’ biosimilars business for $3.34 billion. Kiran Mazumdar Shaw, executive chairperson of Biocon Biologics on Monday said BBL has entered into an agreement with Viatris to acquire its biosimilars business for $3.34 billion, which would include cash of up to $2.34 billion …

Billion Bbl Biocon Biocon Biologics Viatris Biosimilars
Adar Poonawalla commits 100 million doses of vaccines every year to Biocon Biologics
3 years, 3 months ago

Adar Poonawalla commits 100 million doses of vaccines every year to Biocon Biologics

The Hindu  

Biocon Biologics Limited will offer approximately 15% stake to Serum Institute Life Sciences Private Limited at a post-money valuation of $4.9 billion in exchange for committed access to 100 million doses of vaccines per annum for 15 years, primarily from SILS’s upcoming vaccine facility in Pune with commercialisation rights of the SILS vaccine portfolio, including COVID-19 vaccines, for global markets. …

Vaccines Bbl Vaccine Poonawalla Serum Institute Biocon Biologics Biologics Biocon
Biocon Biologics Gets Licence from Adagio Therapeutics for Antibody Treatment of Covid-19
3 years, 4 months ago

Biocon Biologics Gets Licence from Adagio Therapeutics for Antibody Treatment of Covid-19

News 18  

Biocon Biologics, a subsidiary of Biocon, on Monday said it has got a licence from US-based Adagio Therapeutics for an antibody therapy to treat and prevent COVID-19, for India and select markets. Adagio Therapeutics has granted an exclusive licence to the company to manufacture and commercialise an antibody treatment based on ADG20 for India and select emerging markets, Biocon Biologics …

India Biologics Biocon Biocon Biologics Adagio
Biocon Biologics ties up with Voluntis for digital therapeutics for diabetes patients
4 years, 5 months ago

Biocon Biologics ties up with Voluntis for digital therapeutics for diabetes patients

Live Mint  

Biocon Biologics on Tuesday announced a global collaboration agreement with Voluntis to develop and distribute digital therapeutics supporting people with diabetes on biologics therapy. and Voluntis will allow Biocon Biologics to offer therapeutic product 'Insulia' to type 2 diabetes patients across several markets in the world, Biocon Biologics said in a statement. "The demand for at-home treatment and telemedicine solutions …

Biologics Biocon Biocon Biologics Digital Therapeutics Voluntis
Biocon Biologics set to ramp up production of itolizumab
4 years, 5 months ago

Biocon Biologics set to ramp up production of itolizumab

Live Mint  

Biocon Biologics India Ltd will ramp up its capacity to produce itolizumab to avoid any shortage of the drug, which received approval from the Drug Controller General of India late last week for the treatment of a critical covid-19 symptom called cytokine storm, Biocon chairperson Kiran Mazumdar-Shaw said on Monday. The drug was given the approval based on a 30-patient …

India Drug Given Biocon Biocon Biologics